HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

A-factor (Streptomyces)

Subscribe to New Research on A-factor (Streptomyces)

specific bioregulator of Streptomyces griseus; Don't confuse with A factor pheromone

Also Known As:

2-isocapryloyl-3R-hydroxymethyl-gamma-butyrolactone; 2S-isocapryloyl-3S-hydroxymethyl-gamma-butyrolactone; L-factor (Streptomyces); A-factor

Networked: 8605 relevant articles (129 outcomes, 626 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Hu, Z: 4 articles (11/2011 - 08/2000)
2.	Ronco, Alvaro L: 3 articles (01/2012 - 03/2009)
3.	De Stefani, Eduardo: 3 articles (01/2012 - 03/2009)
4.	Deneo-Pellegrini, Hugo: 3 articles (01/2012 - 03/2009)
5.	Boffetta, Paolo: 3 articles (01/2012 - 03/2009)
6.	Acosta, Gisele: 3 articles (01/2012 - 03/2009)
7.	Maehara, Yoshihiko: 3 articles (10/2010 - 07/2005)
8.	Rofstad, Einar K: 3 articles (11/2008 - 03/2005)
9.	Benjaminsen, Ilana C: 3 articles (11/2008 - 03/2005)
10.	Szmitkowski, Maciej: 3 articles (08/2008 - 06/2004)

Related Diseases

1.	Neoplasms (Cancer) 12/01/1978 - "In this tumor system, RAD was most effective when delivered every 2nd or 3rd day, by a factor of 1.25 over the response achieved when the four fractions were delivered every 1 or 4 days. " 08/01/2012 - "Using the optimal conditions (38 kPa peak-negative pressure, 95% duty cycle), ARF-assisted binding of BR55 improved significantly in tumor (by a factor of 7) at a lower agent dose compared with binding without ARF, and it had an insignificant effect on binding in healthy tissue. " 11/01/1987 - "While this will be of very considerable help in the conduct of epidemiological investigations, it is clear that the efficacy of primary prevention will increase with, and indeed depend on, understanding of the mechanisms by which a factor or a series of factors contribute to the malignant transformation of cells and/or to their progression to clinical cancer.(ABSTRACT TRUNCATED AT 400 WORDS)" 01/01/2008 - "IMPT plans significantly improved the tumor coverage and conformation (P < 0.05) and they reduced the averaged mean dose to several organs at risk (OARs) by a factor of 2-3. The low-to-medium dose volumes (0.33-13.2 GyE) were more than doubled by IMRT plans. " 08/01/1995 - "Compared with previous estimates, two new independent evaluations of available information indicate a significantly greater risk of stochastic effects of radiation (cancer and genetic effects) by about a factor of three for radiation workers, including space travelers. " Order ALL the reference details at left...
2.	Infection 09/01/2008 - "Despite successful treatment of the infections, comorbidity was and is a factor that compromises good results. " 01/01/2002 - "The objective of this study was to determine the frequency of the different alleles of HLA class II DQ and DR in HIV-1 infected patients of Caucasians with Guaraní and Toba genetic backgrounds in an effort to determine the prevalence of certain alleles which could signify a factor of susceptibility to or protection against HIV-1 infection. " 08/15/2008 - "Pig farm density could be a factor influencing the local spread of infection and was therefore evaluated for clusters of re-infected sow farms and clusters of sow farms that eliminated the infection. " 04/01/2012 - "The study revealed that 47.2% of students believed in fortune as a factor involved in acquisition of CL infection. " 01/01/2012 - "A series of our study has demonstrated that influenza virus infection induced apoptosis in primary cultured human fetal membrane chorion cells, from which a factor with monocyte differentiation-inducing (MDI) activity was secreted. " Order ALL the reference details at left...
3.	Pain (Aches) 08/01/2010 - "The family members recommended the following as particularly effective care strategies: "Eliminate pain and other symptoms that restrict patient activity (53%);" "Quickly dispose of urine and stools so that they are out of sight (52%);" and "Support patients' efforts to care for themselves (45%)." A factor analysis showed that the expert-recommended care strategies could be categorized into seven different components. " 01/01/2007 - "Pain improved from baseline to 6 months by a factor of 5.2 and disability by 3.8 in the NSAID group compared to 3.6 and 3.5, respectively, in the placebo group. " 12/01/2012 - "Although the influence on pain management related to ethnicity was not a factor in this study, other findings revealed that undertreatment of pain, inadequate assessment, lack of documentation of pain, and lengthy wait times persist in the ED." 03/01/2010 - "They suggest the need for additional studies to clarify causality and determine whether undertreatment of BTP is a factor contributing to adverse pain-related outcomes." 06/01/2008 - "The aim of the present study was to investigate the role of anxiety sensitivity (AS) as a factor relevant to pain and pain persistence. " Order ALL the reference details at left...
4.	Inflammation 07/01/2010 - "The aim of the study was to investigate, whether the presence of inflammation in the first series of prostate biopsies was a factor of risk. " 02/01/1996 - "Our study suggests that Tc-99m HIG is a superior agent to Ga-67 and bacterial affinity can be a factor responsible for HIG accumulation at focal sites of inflammation." 05/01/1995 - "The development of tracheal cartilage degeneration and inflammation of the seromucinous glands of the oropharynx may be a factor causing early mortalities in long-term studies with Fischer-344 (F-344) rats. " 05/31/1933 - "STUDIES ON INFLAMMATION : IX. A FACTOR IN THE MECHANISM OF INVASIVENESS BY PYOGENIC BACTERIA." 10/01/2012 - "Total and abdominal adiposity are associated with inflammation in older adults using a factor analysis approach." Order ALL the reference details at left...
5.	Anoxia (Hypoxia) 06/01/2006 - "To what extent this difference in ion flux response to hypoxia is a factor conferring WL tolerance in barley remains to be answered in future studies." 04/01/2012 - "High LDH activity in roots of plants grown in aeration and in hypoxia indicated pre-adaptation to fluctuating root aeration and could be a factor in the phenotypic plasticity and growth of S. " 01/01/2010 - "While tumour hypoxia caused by anaemia is a factor of radio resistance and thus a source of local failure, tumour expression of EPO receptors presents a significant risk for tumour progression and neo-angiogenesis, which would be increased during the administration of EPO. " 07/01/2009 - "Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?" 06/01/2009 - "Therefore, hypoxia is regarded as a factor of unfavorable prognosis. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2.	Antigens
3.	Retinaldehyde (Retinal)
4.	Lactic Acid
5.	DNA (Deoxyribonucleic Acid)
6.	Factor V (Coagulation Factor V)
7.	Oxygen
8.	Factor VIII (Coagulation Factor VIII)
9.	Iron
10.	Carbon Monoxide

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Photochemotherapy (Photodynamic Therapy)
3.	Transplants (Transplant)
4.	Radiotherapy
5.	Prostheses and Implants (Prosthesis)

blog comments powered by Disqus

TREATMENT OPTIONS
for Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 25767 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$24.95 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$490.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>